Share this:
Published on July 31, 2020 at 04:30PM
The Securities and Exchange Commission today announced that Bausch Health, formerly Quebec, Canada-based Valeant Pharmaceuticals, agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in SEC…
https://ift.tt/39VWArT
More Stories
SEC: SEC Charges U.S. Promoters of $2 Billion Global Crypto Lending Securities Offering
SEC: SEC Charges Mutual Fund Executives with Misleading Investors Regarding Investment Risks in Funds that Suffered $1 Billion Trading Loss
SEC: SEC Awards More Than $4 Million to Whistleblower